CN Stock MarketDetailed Quotes

300630 Hainan Poly Pharm

Watchlist

14.39
+0.20+1.41%

Noon Break Apr 19 11:30 CST

6.50BMarket Cap17.59P/E (TTM)

Hainan Poly Pharm Stock Forum

Moomoo AI

Feb 1 09:29

Despite Hainan Poly Pharm's market-aligned growth forecast, its lower P/E ratio indicates shareholder skepticism. The average earnings outlook with market-like growth suggests potential risks pressuring the P/E ratio. Investors may anticipate future earnings volatility.

Investors Holding Back On Hainan Poly Pharm. Co., Ltd (SZSE:300630)

Moomoo AI

Oct 10, 2023 07:17

Hainan Poly Pharm's significant ROE, steady earnings growth, and efficient reinvestment of retained earnings lead to a standout performance. Experts believe the company's growth rate will remain consistent. Stock rose by 23% within a month, indicating a positive market response.

Is Hainan Poly Pharm. Co., Ltd's (SZSE:300630) Latest Stock Performance A Reflection Of Its Financial Health?

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall